|Intrapleural use of tissue plasminogen activator and DNase in pleural infection|
NM Rahman, NA Maskell, A West, R Teoh, A Arnold, C Mackinlay, ...
New England Journal of Medicine 365 (6), 518-526, 2011
|Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium|
JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ...
Science 354 (6313), 751-757, 2016
|Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers|
M Deakin, J Elder, C Hendrickkse, D Peckham, D Leopard, DA Bell, ...
Oxford University Press 17 (4), 881-884, 1996
|Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study|
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
|European cystic fibrosis society standards of care: framework for the cystic fibrosis centre|
S Conway, IM Balfour-Lynn, K De Rijcke, P Drevinek, J Foweraker, ...
Journal of Cystic Fibrosis 13, S3-S22, 2014
|Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review|
P Wood, S Stanworth, J Burton, A Jones, DG Peckham, T Green, C Hyde, ...
Clinical & Experimental Immunology 149 (3), 410-423, 2007
|Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers|
T Daniels, L Goodacre, C Sutton, K Pollard, S Conway, D Peckham
Chest 140 (2), 425-432, 2011
|Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis|
J Li, K Coulthard, R Milne, RL Nation, S Conway, D Peckham, ...
Journal of Antimicrobial Chemotherapy 52 (6), 987-992, 2003
|Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study|
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
|Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis|
SP Conway, KG Brownlee, M Denton, DG Peckham
American Journal of Respiratory Medicine 2, 321-332, 2003
|Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis|
P Whitaker, X Meng, SN Lavergne, S El-Ghaiesh, M Monshi, C Earnshaw, ...
The Journal of Immunology 187 (1), 200-211, 2011
|Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis|
DR Baldwin, AL Hill, DG Peckham, AJ Knox
Respiratory medicine 88 (1), 49-53, 1994
|Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis|
S El-Ghaiesh, MM Monshi, P Whitaker, R Jenkins, X Meng, J Farrell, ...
Journal of Pharmacology and Experimental Therapeutics 341 (3), 597-610, 2012
|The benefits of 3D modelling and animation in medical teaching|
T Vernon, D Peckham
Journal of Audiovisual media in Medicine 25 (4), 142-148, 2002
|Neurodegenerative disease and the NLRP3 inflammasome|
JA Holbrook, HH Jarosz-Griffiths, E Caseley, S Lara-Reyna, JA Poulter, ...
Frontiers in pharmacology 12, 643254, 2021
|Alcaligenes infection in cystic fibrosis|
K Tan, SP Conway, KG Brownlee, C Etherington, DG Peckham
Pediatric pulmonology 34 (2), 101-104, 2002
|The global impact of SARS-CoV-2 in 181 people with cystic fibrosis|
E McClenaghan, R Cosgriff, K Brownlee, S Ahern, PR Burgel, CA Byrnes, ...
Journal of cystic fibrosis 19 (6), 868-871, 2020
|Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis|
HH Jarosz-Griffiths, T Scambler, CH Wong, S Lara-Reyna, J Holbrook, ...
Elife 9, e54556, 2020
|The burgeoning field of innate immune‐mediated disease and autoinflammation|
D Peckham, T Scambler, S Savic, MF McDermott
The Journal of pathology 241 (2), 123-139, 2017
|ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis|
T Scambler, HH Jarosz-Griffiths, S Lara-Reyna, S Pathak, C Wong, ...
Elife 8, e49248, 2019